Annual Total Long Term Liabilities
$125.86 M
+$119.68 M+1935.66%
December 31, 2023
Summary
- As of February 22, 2025, SYRE annual total long term liabilities is $125.86 million, with the most recent change of +$119.68 million (+1935.66%) on December 31, 2023.
- During the last 3 years, SYRE annual total long term liabilities has risen by +$120.52 million (+2255.70%).
- SYRE annual total long term liabilities is now at all-time high.
Performance
SYRE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$36.16 M
-$3.40 M-8.59%
September 30, 2024
Summary
- As of February 22, 2025, SYRE quarterly total long term liabilities is $36.16 million, with the most recent change of -$3.40 million (-8.59%) on September 30, 2024.
- Over the past year, SYRE quarterly long term liabilities has dropped by -$371.63 million (-91.13%).
- SYRE quarterly long term liabilities is now -91.13% below its all-time high of $407.80 million, reached on September 30, 2023.
Performance
SYRE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SYRE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1935.7% | -91.1% |
| 3 y3 years | +2255.7% | +471.0% |
| 5 y5 years | +10000.0% | +471.0% |
SYRE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2054.8% | -91.1% | +593.4% |
| 5 y | 5-year | at high | +2553.7% | -91.1% | +662.4% |
| alltime | all time | at high | -100.0% | -91.1% | -100.0% |
Spyre Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $36.16 M(-8.6%) |
| Jun 2024 | - | $39.56 M(-86.5%) |
| Mar 2024 | - | $292.51 M(+132.4%) |
| Dec 2023 | $125.86 M(+1935.7%) | $125.86 M(-69.1%) |
| Sep 2023 | - | $407.80 M(+86.5%) |
| Jun 2023 | - | $218.66 M(+3447.4%) |
| Mar 2023 | - | $6.16 M(-0.3%) |
| Dec 2022 | $6.18 M(+5.9%) | - |
| Dec 2022 | - | $6.18 M(-2.4%) |
| Sep 2022 | - | $6.33 M(-5.3%) |
| Jun 2022 | - | $6.69 M(+28.2%) |
| Mar 2022 | - | $5.21 M(-10.7%) |
| Dec 2021 | $5.84 M(+9.3%) | $5.84 M(-10.9%) |
| Sep 2021 | - | $6.55 M(-10.9%) |
| Jun 2021 | - | $7.35 M(-1.8%) |
| Mar 2021 | - | $7.49 M(+40.2%) |
| Dec 2020 | $5.34 M(+12.7%) | $5.34 M(+6.7%) |
| Sep 2020 | - | $5.01 M(+5.1%) |
| Jun 2020 | - | $4.76 M(-1.6%) |
| Mar 2020 | - | $4.84 M(+2.0%) |
| Dec 2019 | $4.74 M | $4.74 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.91 M(+0.9%) |
| Jun 2019 | - | $4.86 M(+1046.2%) |
| Mar 2019 | - | $424.00 K(+488.9%) |
| Dec 2018 | $72.00 K(-35.1%) | $72.00 K(-11.1%) |
| Sep 2018 | - | $81.00 K(-11.0%) |
| Jun 2018 | - | $91.00 K(-9.9%) |
| Mar 2018 | - | $101.00 K(-9.0%) |
| Dec 2017 | $111.00 K(-15.9%) | $111.00 K(-5.1%) |
| Sep 2017 | - | $117.00 K(-4.1%) |
| Jun 2017 | - | $122.00 K(-3.9%) |
| Mar 2017 | - | $127.00 K(-3.8%) |
| Dec 2016 | $132.00 K(+388.9%) | $132.00 K(+407.7%) |
| Sep 2016 | - | $26.00 K(+62.5%) |
| Jun 2016 | - | $16.00 K(-27.3%) |
| Mar 2016 | - | $22.00 K(-18.5%) |
| Dec 2015 | $27.00 K(>+9900.0%) | $27.00 K(-15.6%) |
| Sep 2015 | - | $32.00 K(-13.5%) |
| Jun 2015 | - | $37.00 K(-11.9%) |
| Mar 2015 | - | $42.00 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is Spyre Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics annual total long term liabilities year-on-year change?
- What is Spyre Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly long term liabilities year-on-year change?
What is Spyre Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SYRE is $125.86 M
What is the all time high annual total long term liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total long term liabilities is $125.86 M
What is Spyre Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SYRE annual total long term liabilities has changed by +$119.68 M (+1935.66%)
What is Spyre Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SYRE is $36.16 M
What is the all time high quarterly long term liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total long term liabilities is $407.80 M
What is Spyre Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SYRE quarterly total long term liabilities has changed by -$371.63 M (-91.13%)